Variability of treatment of locally advanced cervical cancer: How French multidisciplinary teams follow European guidelines?

• Published in: European journal of surgical oncology 2024-06, Vol.50 (6), p.108281-108281, Article 108281
• Main Authors: Sabah, Jonathan, Menoux, Ines, Eberst, Lauriane, Lodi, Massimo, Gantzer, Justine, Azais, Henri, El Hajj, Houssein, Balaya, Vincent, Babin, Guillaume, Espenel, Sophie, Dabi, Yohann, Kissel, Manon, Phuong Lien, Tran, Angeles, Martina Aida, Margueritte, Francois, Deluche, Elise, Marouk, Alexis, Le Borgne, Pierrick, Apithy, Mah-Soune, Laas-Faron, Enora, Akladios, Chérif, Lecointre, Lise
• Format: Article
• Language: English
• ISSN: 0748-7983; 1532-2157
• DOI: 10.1016/j.ejso.2024.108281

Cervical cancer is a global public health concern. Despite ESGO recommendations and FIGO classification changes, management of locally advanced cervical cancer (LACC) remains debated in France. Our study aimed to review LACC treatment practices and assess adherence to ESGO recommendations among different practitioners. From February 2021 to August 2022, we conducted a survey among gynecologic oncology surgeons, radiation oncologists, and medical oncologists practicing in France and managing LACC (FIGO stages IB3-IVA) according to the 2018 FIGO classification. We analyzed responses against the 2018 ESGO recommendations as a “gold standard." Among 115 respondents (56% radiation oncologists, 30% surgeons, 13% medical oncologists), 48.6% of gynecologic surgeons didn't perform para-aortic lymphadenectomy (PAL) with significant radiologic pelvic involvement. PAL, when indicated by PET-CT, was more common in university hospitals (66.7% of surgeons). Surgeons in university hospitals also followed ESGO recommendations more closely. Overall, compliance with all ESGO recommendations was low: 5.7% of surgeons, 21.5% of radiation oncologists, and 60% of medical oncologists. Prophylactic para-aortic irradiation, per ESGO, was more frequent in comprehensive cancer centers (52% of radiation oncologists). Adherence to ESGO recommendations for LACC treatment appears low in France, particularly in surgery, with limited PAL in cases of lymph node negativity on PET-CT. However, these recommendations are more often followed by surgeons in university hospitals and radiation oncologists in cancer centers. Adherence to these recommendations may impact patient survival and warrants evaluation of care quality, justifying the organization of LACC management in expert centers.